Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples